CA 125 in gynecological pathology — a review
- 1 April 1993
- journal article
- review article
- Published by Elsevier BV in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 49 (1-2), 115-124
- https://doi.org/10.1016/0028-2243(93)90135-y
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- CA 125 half-life in ovarian cancer: a multivariate survival analysisBritish Journal of Cancer, 1993
- Use of Serum Tumor Markers in the Differential Diagnosis between Ovarian and Colorectal AdenocarcinomasTumor Biology, 1992
- Radioimmunotargeting in ovarian carcinoma patients with indium-111 labeled monoclonal antibody OV-TL 3 F(ab')2: pharmacokinetics, tissue distribution, and tumor imagingInternational Journal of Gynecologic Cancer, 1992
- The CA 125 tumour-associated antigen: a review of the literatureHuman Reproduction, 1989
- Ovarian cancer: The prognostic value of the serum half-life of CA125 during induction chemotherapyGynecologic Oncology, 1988
- An initial analysis of preoperative serum CA 125 levels in patients with early stage ovarian carcinomaGynecologic Oncology, 1988
- Pre-operative discrimination between benign and malignant ovarian tumors using a combination of CA125 and CA15.3 serum assaysInternational Journal of Cancer, 1988
- CA 125: A useful marker in endometrial carcinomaAmerican Journal of Obstetrics and Gynecology, 1986